Beurs gesloten -
Nasdaq
22:00:00 27-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
25,58
USD
|
-0,35%
|
|
-1,16%
|
-19,66%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
96.408
|
161.105
|
172.063
|
192.229
|
140.770
|
113.164
|
-
|
-
|
Bedrijfswaarde
1 |
85.618
|
145.026
|
152.725
|
169.905
|
112.635
|
87.280
|
80.958
|
74.296
|
K/w-verhouding
|
43,5
x
|
34,1
x
|
57,8
x
|
35,2
x
|
32,6
x
|
24,8
x
|
18
x
|
14,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
18
x
|
15,9
x
|
20,3
x
|
13,2
x
|
8,54
x
|
5,71
x
|
4,79
x
|
4
x
|
Bedrijfswaarde/omzet
|
16
x
|
14,3
x
|
18
x
|
11,6
x
|
6,84
x
|
4,41
x
|
3,43
x
|
2,62
x
|
Bedrijfswaarde/EBITDA
|
30,8
x
|
22,1
x
|
46,8
x
|
25,3
x
|
20,1
x
|
13,8
x
|
9,74
x
|
6,8
x
|
Bedrijfswaarde/FCF
|
68,7
x
|
23,7
x
|
77,3
x
|
47,3
x
|
16,1
x
|
32
x
|
13,6
x
|
8,66
x
|
FCF Yield
|
1,46%
|
4,22%
|
1,29%
|
2,12%
|
6,23%
|
3,13%
|
7,35%
|
11,5%
|
Price to Book
|
6,85
x
|
8,5
x
|
7,82
x
|
7,07
x
|
4,5
x
|
3,33
x
|
2,71
x
|
2,27
x
|
Aantal aandelen (in duizenden)
|
65.075
|
65.410
|
65.423
|
65.362
|
65.322
|
63.629
|
-
|
-
|
Referentieprijs
2 |
1.482
|
2.463
|
2.630
|
2.941
|
2.155
|
1.778
|
1.778
|
1.778
|
Datum van publicatie
|
19-02-20
|
23-02-21
|
16-02-22
|
22-02-23
|
14-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
5.366
|
10.111
|
8.482
|
14.595
|
16.474
|
19.804
|
23.620
|
28.307
|
EBITDA
1 |
2.777
|
6.572
|
3.266
|
6.719
|
5.616
|
6.324
|
8.308
|
10.930
|
Bedrijfsresultaat (EBIT)
1 |
2.638
|
6.313
|
3.018
|
6.357
|
5.321
|
5.930
|
7.849
|
10.464
|
Operationele Marge
|
49,16%
|
62,44%
|
35,58%
|
43,56%
|
32,3%
|
29,94%
|
33,23%
|
36,96%
|
Resultaat voor belastingen (EBT)
1 |
2.859
|
5.904
|
3.983
|
7.035
|
5.637
|
5.853
|
8.292
|
10.868
|
Nettowinst (verlies)
1 |
2.166
|
4.758
|
3.008
|
5.522
|
4.352
|
4.667
|
6.544
|
8.323
|
Nettomarge
|
40,37%
|
47,06%
|
35,46%
|
37,83%
|
26,42%
|
23,57%
|
27,71%
|
29,4%
|
WPA
2 |
34,03
|
72,21
|
45,54
|
83,65
|
66,02
|
71,85
|
98,69
|
123,2
|
Free Cash Flow
1 |
1.247
|
6.126
|
1.976
|
3.595
|
7.014
|
2.730
|
5.948
|
8.574
|
FCF-marge
|
23,24%
|
60,59%
|
23,3%
|
24,63%
|
42,58%
|
13,79%
|
25,18%
|
30,29%
|
Kasstroomconversie (ebitda)
|
44,9%
|
93,21%
|
60,5%
|
53,5%
|
124,89%
|
43,17%
|
71,59%
|
78,45%
|
Kasstroomconversie (nettowinst)
|
57,57%
|
128,75%
|
65,69%
|
65,1%
|
161,17%
|
58,5%
|
90,89%
|
103,02%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19-02-20
|
23-02-21
|
16-02-22
|
22-02-23
|
14-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
6.343
|
3.553
|
2.310
|
2.619
|
2.119
|
3.162
|
5.281
|
4.087
|
5.227
|
2.854
|
4.198
|
7.052
|
4.744
|
4.678
|
4.143
|
4.990
|
9.039
|
5.285
|
5.538
|
5.236
|
EBITDA
1 |
4.583
|
1.345
|
905
|
1.016
|
529
|
1.263
|
1.792
|
1.953
|
2.974
|
458
|
1.520
|
1.978
|
1.739
|
1.899
|
823
|
1.508
|
2.412
|
1.712
|
2.045
|
2.850
|
Bedrijfsresultaat (EBIT)
1 |
4.568
|
1.319
|
890
|
809
|
514
|
1.247
|
1.761
|
1.931
|
2.665
|
437
|
1.497
|
1.934
|
1.717
|
1.670
|
801
|
390,3
|
2.229
|
1.632
|
1.819
|
1.547
|
Operationele Marge
|
72,02%
|
37,12%
|
38,53%
|
30,89%
|
24,26%
|
39,44%
|
33,35%
|
47,25%
|
50,99%
|
15,31%
|
35,66%
|
27,42%
|
36,19%
|
35,7%
|
19,33%
|
7,82%
|
24,66%
|
30,87%
|
32,84%
|
29,54%
|
Resultaat voor belastingen (EBT)
1 |
4.682
|
1.846
|
1.171
|
966
|
612
|
2.489
|
3.101
|
3.272
|
662
|
286
|
1.723
|
2.009
|
2.702
|
926
|
1.716
|
198,8
|
3.374
|
1.714
|
1.687
|
1.634
|
Nettowinst (verlies)
1 |
3.647
|
1.402
|
890
|
716
|
465
|
1.891
|
2.356
|
2.582
|
584
|
226
|
1.357
|
1.583
|
2.129
|
640
|
1.325
|
463,4
|
2.598
|
1.371
|
1.274
|
1.280
|
Nettomarge
|
57,5%
|
39,46%
|
38,53%
|
27,34%
|
21,94%
|
59,8%
|
44,61%
|
63,18%
|
11,17%
|
7,92%
|
32,32%
|
22,45%
|
44,88%
|
13,68%
|
31,98%
|
9,29%
|
28,74%
|
25,95%
|
23%
|
24,45%
|
WPA
2 |
55,52
|
21,25
|
13,47
|
10,82
|
7,050
|
28,66
|
35,71
|
39,17
|
8,820
|
3,430
|
20,61
|
24,03
|
32,32
|
9,670
|
20,18
|
2,980
|
39,51
|
19,53
|
20,65
|
21,13
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12-08-20
|
11-08-21
|
10-11-21
|
16-02-22
|
11-05-22
|
10-08-22
|
10-08-22
|
09-11-22
|
22-02-23
|
10-05-23
|
03-08-23
|
03-08-23
|
07-11-23
|
14-02-24
|
02-05-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
10.790
|
16.079
|
19.338
|
22.324
|
28.135
|
25.884
|
32.206
|
38.868
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1.247
|
6.126
|
1.976
|
3.595
|
7.014
|
2.730
|
5.948
|
8.574
|
ROE (netto-inkomsten/eigen vermogen)
|
19,6%
|
28,7%
|
14,6%
|
22,2%
|
14,8%
|
15,3%
|
16,2%
|
17,8%
|
ROA (netto-inkomsten/totale activa)
|
18,4%
|
26,2%
|
13,1%
|
20,1%
|
13,3%
|
13,8%
|
13,9%
|
16,1%
|
Totale activa
1 |
11.803
|
18.143
|
22.885
|
27.453
|
32.704
|
33.739
|
46.969
|
51.593
|
Nettoactief per aandeel
2 |
216,0
|
290,0
|
336,0
|
416,0
|
479,0
|
534,0
|
657,0
|
784,0
|
Cashflow per aandeel
2 |
21,50
|
97,60
|
33,70
|
59,30
|
112,0
|
87,50
|
126,0
|
163,0
|
Capex
1 |
79
|
307
|
252
|
317
|
366
|
480
|
515
|
647
|
Capex/omzet
|
1,47%
|
3,04%
|
2,97%
|
2,17%
|
2,22%
|
2,42%
|
2,18%
|
2,29%
|
Datum van publicatie
|
19-02-20
|
23-02-21
|
16-02-22
|
22-02-23
|
14-02-24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
1.778
DKK Gemiddelde koersdoel
2.464
DKK Spread / Gemiddelde doel +38,54% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +16,13% | 122 mld. | | +19,65% | 113 mld. | | +21,22% | 26,49 mld. | | -23,84% | 19,4 mld. | | -45,95% | 15,15 mld. | | -19,28% | 15,4 mld. | | +63,81% | 14,93 mld. | | +1,94% | 13,52 mld. | | +116,04% | 10,79 mld. |
Biotherapeutische geneesmiddelen
|